Therapeutics
Found 12 companies.
🏒 Hinge Health
πŸ‘₯ 1001-5000πŸ’° $400.0m Series E on 2021-10-28TherapeuticsMedicalWearablesHealth Care
Website LinkedIn Email Phone # Facebook Twitter

One in two people experience debilitating back, neck, shoulder, or joint pain β€” but traditional treatments have failed to meet their needs. Physical therapy can be expensive and hard to access; appointments often involve long commutes and missed work. Making matters worse, unresolved pain can trigger the overuse of opioids and surgeries. We’re making high-quality care accessible by pairing wearable sensors and computer vision with a world-class clinical team. Hinge Health puts a digital clinic in every member's pocket. Now millions of people can access personalized digital care from a physical therapist, guidance on behavior change from a health coach, and expert consultations with an orthopedic surgeon. With a single app and wearable technology like our Enso device, we’re helping empower people to move beyond pain.

🏒 Daybreak Health
πŸ‘₯ 51-200πŸ’° $13.0m Series B on 2023-08-08Personal HealthMental HealthTherapeuticsMobile AppsHealth Care
Website LinkedIn Email Phone # Facebook Twitter

Daybreak Health is a San Francisco-based startup founded in 2019 that specializes in providing online counseling services for teens. Their mobile app connects teens to teen-specialized therapists, helping to stabilize their mental fitness.

🏒 Vetsource
πŸ‘₯ 501-1000πŸ’° $50.0m Series D on 2018-06-05PharmaceuticalWarehousingProduct DesignTherapeuticsMedicalE-Commerce PlatformsManufacturing
Website LinkedIn Email Phone # Facebook Twitter

Vetsource is a company that provides a range of solutions for the veterinary industry, including prescription management, pet owner engagement, and e-commerce services. They ensure quality and authenticity of products through their human-grade pharmacy warehouse sourced directly from manufacturers.

🏒 Affini-T Therapeutics
πŸ‘₯ 101-250πŸ’° $175.0m on 2022-03-22BiotechnologyTherapeuticsHealth Care
Website LinkedIn Twitter

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer. Affini-T uses a validated platform to select high-affinity T cell receptors specific to oncogenic mutations to pioneer cutting-edge solid tumor therapies. Affini-T leverages gene editing and synthetic biology to engineer novel T-cell therapies designed to eradicate tumors.

🏒 Crinetics Pharmaceuticals
πŸ‘₯ 251-500πŸ’° $350.0m Post-IPO Equity on 2023-09-13PharmaceuticalBiotechnologyTherapeuticsHealth Care
Website LinkedIn Phone # Facebook Twitter

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.

🏒 Apogee Therapeutics
πŸ‘₯ 101-250πŸ’° $149.0m Series B on 2022-12-07BiotechnologyTherapeuticsMedicalLife Science
Website LinkedIn

Apogee Therapeutics is a San Francisco-based biotechnology company, established in 2022, focused on developing innovative therapies for immunological and inflammatory disorders to meet patient needs.

🏒 argenx
πŸ‘₯ 501-1000πŸ’° $1.1B Post-IPO Equity on 2023-07-19BiotechnologyTherapeuticsClinical Trials
Website LinkedIn Email Phone # Twitter

argenx is a global immunology company dedicated to enhancing the quality of life for individuals afflicted with severe autoimmune diseases and cancer.

🏒 Caribou Biosciences
πŸ‘₯ 101-250πŸ’° $125.0m Post-IPO Equity on 2023-07-13BiotechnologyTherapeuticsOncologyHealth Care
Website LinkedIn Email Phone # Facebook Twitter

Caribou Biosciences is a medical technology company that specializes in cell and genome engineering using the CRISPR-Cas9 technology platform. The company focuses on developing therapeutics for agricultural and industrial biotechnology, as well as basic and applied biological research.

🏒 Caidya
πŸ‘₯ 1001-5000πŸ’° $ Series D on 2023-04-17BiotechnologyTherapeuticsmHealthClinical TrialsMedical
Website LinkedIn Email Twitter

Caidya is a clinical research organization based in North Carolina, USA, founded in 2021. It specializes in providing personalized solutions for various therapeutic areas by utilizing a proprietary technology platform that integrates data from different systems to create a near real-time view of clinical trials.

🏒 Headspace
πŸ‘₯ 501-1000πŸ’° $105.0m Debt Financing on 2023-07-26πŸ«‚ on 2023-06-29InternetMental HealthTherapeuticsmHealthMedicalFitnessMobile AppsHealth Care
Website LinkedIn Email Phone # Facebook Twitter

Headspace is a mental health company that offers a comprehensive guide to better mental well-being through its app, providing meditation, sleep support, movement exercises, and more. By combining technology with expert care, including coaching and therapy, Headspace aims to make mental health accessible to everyone, enhancing productivity and overall health.

Shown 10 out of 12